Overview

Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder

Status:
Completed
Trial end date:
2010-12-06
Target enrollment:
Participant gender:
Summary
This is an outpatient study to evaluate the safety, and efficacy of RGH-188 as an add-on therapy to standard antidepressants in patients who did not respond to previous antidepressant therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Forest Laboratories
Collaborator:
Gedeon Richter Ltd.
Treatments:
Antidepressive Agents
Cariprazine